Eric Harold Yecies is CCO at LifeMD, Inc. (LFMD). They have made 6 open-market trades across 1 company since 2021, most recently 2025-08-22.
CIK 0001834563
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $279K since 2021, against 1 sale. Across 5 scored buys the stock is down 14.5% at ninety days, and 14.2 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| LFMD | 388,900 | $914K |
Shares reported on the most recent Form 4, priced at the 2025-08-26 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 80% | 60% | 20% |
| Avg Move | +6.9% | +11.8% | -14.5% |
| Alpha | +5.6% | +9.9% | -14.2% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LFMD | SELL | 2025-06-13 | 2025-06-17 | $12.25 | $184K | -2.8% | -20.8% | -58.4% |
| LFMD | BUY | 2023-06-13 | 2023-06-14 | $2.60 | $30K | +22.3% | +36.2% | +56.8% |
| LFMD | BUY | 2022-03-14 | 2022-03-15 | $3.14 | $16K | +5.2% | +0.0% | -33.2% |
| LFMD | BUY | 2021-11-23 | 2021-11-23 | $4.12 | $30K | +3.7% | +6.7% | -13.6% |
| LFMD | BUY | 2021-05-19 | 2021-05-19 | $9.24 | $103K | +19.6% | +25.1% | -35.8% |
| LFMD | BUY | 2021-02-25 | 2021-02-25 | $20.08 | $100K | -16.3% | -8.9% | -46.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.